In Vitro and In Vivo Efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae

T-3811, the free base of T-3811ME (BMS-284756), a new des-F(6)-quinolone, showed a potent in vitro activity (MIC at which 90% of the isolates tested are inhibited [MIC(90)], 0.0313 μg/ml) against Mycoplasma pneumoniae. The MIC(90) of T-3811 was 4-fold higher than that of clarithromycin but was 4- to...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Takahata, Masahiro, Shimakura, Masako, Hori, Ritsuko, Kizawa, Kazuo, Todo, Yozo, Minami, Shinzaburo, Watanabe, Yasuo, Narita, Hirokazu
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2001
נושאים:
Experimental Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC90281/
https://ncbi.nlm.nih.gov/pubmed/11120986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.1.312-315.2001
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים